Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
54.84
-0.54 (-0.98%)
Apr 28, 2026, 3:00 PM CST

SHA:600276 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
40,52740,95524,81620,74615,11113,631
Trading Asset Securities
108.92113.84273.3499.052,7605,090
Cash & Short-Term Investments
40,63641,06925,08920,84517,87118,721
Cash Growth
67.95%63.69%20.36%16.64%-4.54%13.93%
Accounts Receivable
6,4925,9096,1596,1358,3416,884
Other Receivables
15.6528.1766.41438.25562.18658
Receivables
6,5075,9386,2266,5738,9047,542
Inventory
2,8862,8782,4172,3142,4512,403
Prepaid Expenses
-166.79239.54226.07507.2431.57
Other Current Assets
2,0151,4381,3431,3291,2011,090
Total Current Assets
52,04451,49035,31531,28730,93430,188
Property, Plant & Equipment
8,1287,9086,9286,6296,6766,276
Long-Term Investments
2,1332,0301,7321,4511,5081,001
Other Intangible Assets
2,2591,9561,192883.77519.9442.45
Long-Term Deferred Tax Assets
772.03780.96377.17320.56238.9141.36
Long-Term Deferred Charges
5,3715,0904,1122,8292,052569.38
Other Long-Term Assets
586.84611.69479.11383.3442.55648.99
Total Assets
71,29469,86750,13643,78542,37139,266
Accounts Payable
2,3351,9951,5171,3341,4931,920
Accrued Expenses
1.631,405941.05578.8597.57165.66
Short-Term Debt
----1,261-
Current Portion of Leases
30.3730.9341.13---
Current Income Taxes Payable
769.97633.05242.9459.284.0321.77
Current Unearned Revenue
1,4541,913159.79198.09187.08219.55
Other Current Liabilities
1,046392.96731.36383.42596.131,074
Total Current Liabilities
5,6376,3693,6342,5543,6393,402
Long-Term Leases
37.143.3169.0475.1898.86151.59
Long-Term Unearned Revenue
1,3011,541225.6538.95119.44116.52
Long-Term Deferred Tax Liabilities
172.15116.96117.1183.64100.4524.77
Total Liabilities
7,1478,0704,0452,7513,9583,694
Common Stock
6,6376,6376,3796,3796,3796,396
Additional Paid-In Capital
12,88312,9353,1883,0583,0203,356
Retained Earnings
45,88443,60137,16432,10228,81925,928
Treasury Stock
-1,793-1,929-1,229-1,092-398.03-664.94
Comprehensive Income & Other
15.727.9616.9719.323.23-12.16
Total Common Equity
63,62661,27245,52040,46637,82435,003
Minority Interest
520.82524.75570.39567.29589.35568.85
Shareholders' Equity
64,14761,79746,09041,03338,41335,572
Total Liabilities & Equity
71,29469,86750,13643,78542,37139,266
Total Debt
67.4774.23110.1675.181,360151.59
Net Cash (Debt)
40,56840,99524,97920,77016,51118,570
Net Cash Growth
68.42%64.12%20.27%25.79%-11.08%13.00%
Net Cash Per Share
-6.273.943.282.582.91
Filing Date Shares Outstanding
-6,5346,3626,3616,3676,382
Total Common Shares Outstanding
-6,5346,3626,3616,3676,382
Working Capital
46,40745,12131,68128,73427,29526,786
Book Value Per Share
-9.387.166.365.945.48
Tangible Book Value
61,36759,31644,32839,58237,30434,561
Tangible Book Value Per Share
-9.086.976.225.865.42
Buildings
-4,8923,9753,8543,5412,700
Machinery
-6,5236,1045,9695,6845,120
Construction In Progress
-2,0061,6881,1011,1931,659
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.